Ahmadzadehfar, Hojjat; Essler, Markus; Rahbar, Kambiz; Afshar Oromieh, Ali (2018). Radionuclide Therapy for Bone Metastases: Utility of Scintigraphy and PET Imaging for Treatment Planning. PET clinics, 13(4), pp. 491-503. Elsevier 10.1016/j.cpet.2018.05.005
Full text not available from this repository. (Request a copy)The skeleton is a common site for cancer metastases. Bone metastases are a major cause of morbidity and mortality and associated with pain, pathologic fractures, spinal cord compression, and decreased survival. Various radionuclides have been used for pain therapy. Recently, an α-emitter has been shown to improve overall survival of patients with bone metastases from castration-resistant prostate cancer and was approved as a therapeutic agent. The aim of this article is to provide an overview regarding state of the art radionuclide therapy options for bone metastases, with focus on the role of PET imaging in therapy planning.
Item Type: |
Journal Article (Review Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine |
UniBE Contributor: |
Afshar Oromieh, Ali |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1556-8598 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Sabine Lanz |
Date Deposited: |
15 Apr 2019 15:07 |
Last Modified: |
05 Dec 2022 15:25 |
Publisher DOI: |
10.1016/j.cpet.2018.05.005 |
PubMed ID: |
30219184 |
URI: |
https://boris.unibe.ch/id/eprint/125640 |
Actions (login required)
 |
Edit item |